Single centre experience of efficacy and toxicity of reduced-dose melphalan conditioning (140 mg/m2 or 110 mg/m2) in autologous stem cell transplantation for multiple myeloma

被引：0
|
作者：
Troy-Barnes, E. [1 ]
Melotti, D. [1 ]
Camilleri, M. [1 ]
Horder, J. [1 ]
Newrick, F. [1 ]
Marfil, J. [1 ]
Lee, L. [2 ]
Mahmood, A. S.
Wisniowski, B.
Papanikolaou, X. [1 ]
Wechalekar, A. [3 ]
Sive, J. [1 ]
Popat, R. [4 ]
Yong, K. [2 ]
Rabin, N. [1 ]
Kyriakou, C. [1 ]
机构：
[1] Univ Coll London Hosp NHS Fdn Trust, London, England
[2] UCL, Inst Canc, London, England
[3] UCL, Ctr Amyloidosis & Acute Phase Prot, London, England
[4] Univ Coll London Hosp, Clin Res Facil, Natl Inst Hlth Res, London, England
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P146
引用
收藏
页码：178 / 179
页数：2
相关论文
共 50 条
  • [1] Multiple myeloma: a comparison of two melphalan conditioning regimens (200 mg/m2 versus 140 mg/m2) for autologous stem cell transplantation
    Julve, M.
    Hassan, S.
    Matthews, J.
    Farrell, M.
    Guy, A.
    Popat, R.
    Smith, M.
    Oakervee, H.
    Gribben, J.
    Cavenagh, J.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S226 - S227
  • [2] EFFECT OF MELPHALAN 140 MG/M2 OR 200 MG/M2 OUTCOMES IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION A MULTIPLE CENTER EXPERIENCE IN SPAIN
    Diez Campos, Isabel
    Gomez Horsfield, Beatriz
    Arevalo, Carolina
    Abril, Laura
    Quinones, Shiomara
    Morgades, Mireia
    Talarn, Carme
    Angona, Anna
    Coll, Rosa
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 487 - 487
  • [3] Effect of Melphalan 140 Mg/m2 Versus 200 Mg/m2 on Toxicities and Outcomes in Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Transplantation
    Katragadda, Lakshmikanth
    McCullough, Lindsay
    Dai, Yunfeng
    Hsu, Jack W.
    Hiemenz, John W.
    May, W. Stratford
    Cogle, Christopher R.
    Norkin, Maxim
    Brown, Randy A.
    Wingard, John R.
    Chang, Myron
    Moreb, Jan S.
    BLOOD, 2015, 126 (23)
  • [4] Effect of melphalan 140 mg/m2 vs 200 mg/m2 on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience
    Katragadda, Lakshmikanth
    McCullough, Lindsay M.
    Dai, Yunfeng
    Hsu, Jack
    Byrne, Michael
    Hiemenz, John
    May, Stratford
    Cogle, Christopher R.
    Norkin, Maxim
    Brown, Randy A.
    Wingard, John R.
    Chang, Myron
    Moreb, Jan S.
    CLINICAL TRANSPLANTATION, 2016, 30 (08) : 894 - 900
  • [5] Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience
    Melotti, Dario
    Asher, Samir
    Troy-Barnes, Ethan
    Nesr, George
    Wilson, William
    Camilleri, Marquita
    Popat, Rakesh
    Xu, Ke
    Rabin, Neil
    Sive, Jonathan
    Papanikolaou, Xenofon
    Lee, Lydia
    Mcmillan, Annabel
    Yong, Kwee
    Kyriakou, Chara
    EJHAEM, 2024, 5 (05): : 1102 - 1106
  • [6] A RETROSPECTIVE ANALYSIS OF 210 mg/m2 AND 140 mg/m2 OF MELPHALAN IN ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Goto, Kimitoshi
    Higuchi, Kohei
    Sato, Maho
    Okada, Yosuke
    Inoue, Shota
    Inoue, Masami
    Sawada, Akihisa
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [7] Comparison of 140mg/m2 vs 200mg/m2 Dose of Melphalan in Myeloma Autograft - a Single Centre Experience from Chennai, India
    Kumar, Kishore
    Subash, Chezhian
    BLOOD, 2020, 136
  • [8] High-dose melphalan 180 mg/m2 with autologous blood stem cell transplantation for multiple myeloma.
    Dimopoulos, MA
    Papadimitriou, C
    Kostis, E
    Kouvelis, V
    Zomas, A
    Grigoraki, V
    Vervessou, E
    Sakarellou, N
    Panayiotides, P
    Anagnostopoulos, N
    BLOOD, 1999, 94 (10) : 399B - 399B
  • [9] Double Transplantation with Melphalan (200 mg/m2) Compared with Triple Transplantation with Intermediate Dose Melphalan (100 mg/m2) in Patients with Multiple Myeloma
    Ludwig, Heinz
    Spicka, Ivan
    Linkesch, Werner
    Greil, Richard
    Kasparu, Hedwig
    Gunsilius, Eberhard
    Thaler, Josef
    Drach, Johannes
    Kuhn, Ingrid
    Weissmann, Adalbert
    Hinke, Axel
    BLOOD, 2008, 112 (11) : 1139 - 1139
  • [10] Safety of High-Dose Melphalan (200 Mg/M2) as Conditioning for Autologous Stem Cell Transplantation for Myeloma in Elderly Patients
    Desai, Amrita
    Beitinjaneh, Amer
    Ramdial, Jeremy
    Ali, Robert
    Lekakis, Lazaros
    Pereira, Denise
    Kimble, Erik
    Florou, Vaia
    Bravo, Gabriela
    Goodman, Mark
    Byrnes, John J.
    Jimenez, Antonio M.
    Saneeymehri, Seyyedeh
    Komanduri, Krishna V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S127 - S128
12345